SUPERNUS PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$9.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$21.66M, a 965.67% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $12.43M.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $6.91M, a 36.12% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $11.14M, a 535.71% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $13.18M, a 31.90% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $19.35M, a 5694.01% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $334.00K.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$12.30M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$9.23M 10-Q · filed 2026-08-03 | -$2.32M derived: sum of 3 quarters · filed 2026-08-03 | $8.82M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $12.43M 10-Q · filed 2026-05-05 | $19.34M derived: sum of 2 quarters · filed 2026-05-05 | $30.48M derived: sum of 3 quarters · filed 2026-05-05 | $32.98M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $6.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $18.05M derived: sum of 2 quarters · filed 2026-03-02 | $20.55M derived: sum of 3 quarters · filed 2026-08-03 | $13.18M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.65M derived: sum of 2 quarters · filed 2026-08-03 | $6.27M 10-Q · filed 2025-11-06 | $17.08M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$4.87M 10-Q · filed 2026-08-03 | $5.94M derived: sum of 3 quarters · filed 2026-08-03 | $7.69M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | -$7.37M 10-Q · filed 2026-05-05 | $3.44M derived: sum of 2 quarters · filed 2026-05-05 | $5.19M derived: sum of 3 quarters · filed 2026-05-05 | $4.46M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.56M derived: sum of 2 quarters · filed 2026-03-02 | $11.84M derived: sum of 3 quarters · filed 2026-03-02 | $19.35M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.02M derived: sum of 2 quarters · filed 2025-11-06 | $8.54M 10-Q · filed 2025-11-06 | $738.00K derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-06-30 | -$728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $6.79M 10-Q · filed 2025-08-05 | -$1.01M derived: sum of 3 quarters · filed 2026-03-02 | -$21.42M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-03-31 | $7.52M 10-Q · filed 2025-05-06 | -$287.00K derived: sum of 2 quarters · filed 2026-03-02 | -$20.69M derived: sum of 3 quarters · filed 2026-03-02 | $7.51M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2023-12-31 | -$7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$28.21M derived: sum of 2 quarters · filed 2026-03-02 | -$7.00K derived: sum of 3 quarters · filed 2026-03-02 | $334.00K 10-K · filed 2026-03-02 | ||||
| 2023-09-30 | -$20.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $7.80M derived: sum of 2 quarters · filed 2024-11-04 | $8.14M 10-Q · filed 2024-11-04 | -$1.07M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $28.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $28.54M 10-Q · filed 2024-08-06 | $19.34M derived: sum of 3 quarters · filed 2025-02-25 | $18.11M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $341.00K 10-Q · filed 2024-05-08 | -$8.86M derived: sum of 2 quarters · filed 2025-02-25 | -$10.10M derived: sum of 3 quarters · filed 2025-02-25 | -$10.90M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$10.44M derived: sum of 2 quarters · filed 2025-02-25 | -$11.24M derived: sum of 3 quarters · filed 2025-02-25 | -$12.30M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.04M derived: sum of 2 quarters · filed 2023-11-08 | -$3.10M 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | -$805.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.87M 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$1.06M 10-Q · filed 2023-05-09 | |||||||
| 2021-09-30 | -$4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $13.35M 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | $18.00M 10-Q · filed 2022-08-08 | |||||||
| 2020-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $11.73M 10-Q · filed 2021-11-05 | ||||||
| 2020-06-30 | $5.94M 10-Q · filed 2021-08-06 | |||||||
| 2017-03-31 | $1.62M 10-Q · filed 2017-05-09 | $372.00K derived: sum of 2 quarters · filed 2017-05-09 | $1.30M derived: sum of 3 quarters · filed 2017-05-09 | -$428.00K derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$317.00K derived: sum of 2 quarters · filed 2017-03-16 | -$2.05M derived: sum of 3 quarters · filed 2017-03-16 | -$2.31M 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $929.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-01-20 | -$800.00K derived: sum of 2 quarters · filed 2017-01-23 | -$1.06M 10-Q · filed 2017-01-20 | -$2.27M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-06-30 | -$1.73M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2017-01-23 | -$1.99M 10-Q/A · filed 2017-01-23 | -$3.20M derived: sum of 3 quarters · filed 2017-05-09 | -$1.15M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-03-31 | -$260.00K 10-Q · filed 2017-05-09 | -$1.47M derived: sum of 2 quarters · filed 2017-05-09 | $584.00K derived: sum of 3 quarters · filed 2017-05-09 | $1.36M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | -$1.21M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $844.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.62M derived: sum of 3 quarters · filed 2017-03-16 | $1.58M 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | $2.06M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-01-20 | $2.83M derived: sum of 2 quarters · filed 2017-01-23 | $2.79M 10-Q/A · filed 2017-01-20 | $2.68M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $776.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-01-23 | $738.00K 10-Q/A · filed 2017-01-23 | $626.00K derived: sum of 3 quarters · filed 2017-03-16 | $863.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$38.00K 10-Q/A · filed 2017-01-20 | -$150.00K derived: sum of 2 quarters · filed 2017-03-16 | $87.00K derived: sum of 3 quarters · filed 2017-03-16 | $446.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | -$112.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $125.00K derived: sum of 2 quarters · filed 2017-03-16 | $484.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.14M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $237.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $596.00K derived: sum of 2 quarters · filed 2017-01-20 | $1.26M 10-Q/A · filed 2017-01-20 | $1.25M 10-Q · filed 2014-11-12 | $1.32M derived: sum of 4 quarters · filed 2017-01-20 | |||
| 2014-06-30 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.02M 10-Q · filed 2015-08-07 | $1.01M 10-Q · filed 2014-08-12 | $1.09M derived: sum of 3 quarters · filed 2017-01-20 | $990.00K derived: sum of 4 quarters · filed 2017-01-20 | |||
| 2014-03-31 | $660.00K 10-Q · filed 2015-05-06 | $507.00K 10-Q · filed 2014-05-13 | $727.00K derived: sum of 2 quarters · filed 2017-01-20 | $631.00K derived: sum of 3 quarters · filed 2017-01-20 | $1.68M derived: sum of 4 quarters · filed 2017-01-20 | |||
| 2013-12-31 | $67.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | -$29.00K derived: sum of 2 quarters · filed 2017-01-20 | $1.02M derived: sum of 3 quarters · filed 2017-01-20 | $889.00K 10-K/A · filed 2017-01-20 | $1.07M 10-K · filed 2014-03-21 | |||
| 2013-09-30 | -$96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $956.00K derived: sum of 2 quarters · filed 2014-11-12 | $822.00K 10-Q · filed 2014-11-12 | $1.41M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $918.00K 10-Q · filed 2014-08-12 | $1.50M derived: sum of 3 quarters · filed 2015-03-12 | $1.55M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$134.00K 10-Q · filed 2014-05-13 | -$133.00K 10-Q · filed 2013-05-15 | $449.00K derived: sum of 2 quarters · filed 2015-03-12 | $502.00K derived: sum of 3 quarters · filed 2015-03-12 | $888.00K derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $636.00K derived: sum of 2 quarters · filed 2015-03-12 | $1.02M derived: sum of 3 quarters · filed 2015-03-12 | $1.18M 10-K · filed 2015-03-12 | $516.00K 10-K · filed 2013-03-15 | |||
| 2012-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $439.00K derived: sum of 2 quarters · filed 2013-11-13 | $597.00K 10-Q · filed 2013-11-13 | $938.00K 10-Q · filed 2012-11-02 | $707.00K derived: sum of 4 quarters · filed 2014-03-21 | |||
| 2012-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $544.00K 10-Q · filed 2013-08-14 | $654.00K derived: sum of 3 quarters · filed 2014-03-21 | -$501.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2012-03-31 | $158.00K 10-Q · filed 2013-05-15 | $268.00K derived: sum of 2 quarters · filed 2014-03-21 | -$887.00K derived: sum of 3 quarters · filed 2014-03-21 | -$1.17M derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2011-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$1.04M derived: sum of 2 quarters · filed 2014-03-21 | -$1.32M derived: sum of 3 quarters · filed 2014-03-21 | $247.00K 10-K · filed 2014-03-21 | ||||
| 2011-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$1.43M derived: sum of 2 quarters · filed 2012-11-02 | $137.00K 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | -$278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $1.29M 10-Q · filed 2012-08-13 | ||||||
| 2011-03-31 | $1.57M 10-Q · filed 2012-06-08 | |||||||
| 2010-12-31 | -$74.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |